Bank of Nova Scotia
AMED

Bank of Nova Scotia’s Amedisys AMED Stock Holding History

Bank of Nova Scotia’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-136,000
Closed -$13.4M – 1052
2025
Q2 		$13.4M Sell
136,000
-6,000
-4% -$568K 0.03% 329
2025
Q1 		$13.2M Buy
142,000
+31,000
+28% +$2.86M 0.03% 320
2024
Q4 		$10.1M Buy
111,000
+71,000
+178% +$6.52M 0.02% 413
2024
Q3 		$3.86M Sell
40,000
-144,774
-78% -$14.1M 0.01% 518
2024
Q2 		$17M Hold
184,774
– – 0.03% 283
2024
Q1 		$17M Sell
184,774
-88,722
-32% -$8.31M 0.03% 295
2023
Q4 		$26M Sell
273,496
-12,061
-4% -$1.13M 0.05% 261
2023
Q3 		$26.7M Buy
+285,557
New +$26.4M 0.07% 196
2022
Q1 		– Sell
-45,307
Closed -$7.34M – 1193
2021
Q4 		$7.34M Buy
+45,307
New +$7.28M 0.01% 613
2021
Q3 		– Sell
-2,020
Closed -$495K – 1107
2021
Q2 		$495K Buy
2,020
+191
+10% +$50.1K ﹤0.01% 985
2021
Q1 		$484K Sell
1,829
-6,390
-78% -$1.8M ﹤0.01% 944
2020
Q4 		$2.41M Buy
8,219
+5,843
+246% +$1.5M 0.01% 667
2020
Q3 		$562K Buy
+2,376
New +$540K ﹤0.01% 851
2020
Q2 		– Sell
-4,250
Closed -$780K – 914
2020
Q1 		$780K Sell
4,250
-34,550
-89% -$6.15M ﹤0.01% 717
2019
Q4 		$6.48M Sell
38,800
-19,997
-34% -$2.97M 0.02% 474
2019
Q3 		$7.7M Buy
+58,797
New +$7.65M 0.02% 422

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of Nova Scotia's AMED Position: Q3 2025 in Review

Bank of Nova Scotia sold out of Amedisys (AMED) in Q3 2025, closing a stake of 136,000 shares — an estimated $13.4M sold.

Bank of Nova Scotia first reported a position in AMED in Q3 2019 and held it in 16 quarters. The position peaked at $26.7M in Q3 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Bank of Nova Scotia reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Bank of Nova Scotia sold 136,000 Amedisys shares in Q3 2025, an estimated $13.4M.
  • Bank of Nova Scotia first reported a position in Amedisys in Q3 2019 and held it in 16 quarters.
  • Bank of Nova Scotia's Amedisys position peaked at $26.7M in Q3 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Bank of Nova Scotia's 13F filing for Q3 2025, filed 14 Nov 2025.